MDACC Study Summary ID03-0211

Study Summary
No. ID03-0211:.......Gynecology......Susan Peterson......Behavioral Science

Study Summary Title



Study Summary Number:	ID03-0211

Study Title:	Screening for Gynecologic Cancers Among Women with HNPCC

Physician

New Patient Referral



Name:	Susan Peterson	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	Behavioral Science	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-792-8267 Contact us about clinical trials

General Information



Disease Group:	Gynecology	Supported By:	N/A

Phase of Study:	N/A	Return Visit:	Not applicable

Treatment Agents:	None	Home Care:	Not applicable

Treatment Loc:	Only at MDACC

Estimated Length of Stay in Houston:	Not applicable

Description/
Intervention:

The goal of this psychosocial research study is to evaluate women's awareness,
attitudes, and behaviors with regards to endometrial cancer (cancer of the
lining of the uterus or womb) and ovarian cancer screening recommendations for
persons at risk of HNPCC-related cancers. Another goal is to study how
families at risk for HNPCC communicate about endometrial and ovarian cancer
risk, and how this risk information is shared with health care providers. A
third goal of the study is to find out what women think of potential cancer
screening and prevention strategies for endometrial, ovarian and colon cancers.

Study Objectives / Outcomes

Among women with HNPCC, this study will assess:
1. Knowledge of screening recommendations for endometrial and ovarian cancers.
2. Perceived risk and cancer worries regarding endometrial, ovarian and colorectal cancers.
3. Adherence to screening recommendations for endometrial, ovarian and colon cancers.
4. Perceived benefits,supports and barriers to endometrial and ovarian cancer screening.
5. Patterns of communication about endometrial and ovarian cancer risk within families with HNPCC and with health care providers.
6. Patient preferences for potential cancer screening and cancer prevention strategies related to HNPCC-associated cancers.

This study will collect preliminary, descriptive data to be used in the development of a larger, multidisciplinary study focusing on screening for gynecologic cancers among women at risk for HNPCC.

Study Status Information



Study Activation / Registration Date:

IRB Review and Approval Date:	05/05/2003

Study Type:

Recruitment Status:	Closed

Projected Accrual:	95

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) Being female

2) Being 25 years of age or older

3) Having an HNPCC-predisposing mutation and/or having a family history of cancer that meets the Amsterdam or Amsterdam II criteria for HNPCC

Exclusion Criteria:

1) Persons who have tested negative for a known HNPCC-predisposing mutation in their family

2) Persons who have no family HNPCC mutation and have not met the Amsterdam I/II criteria

3) Being younger than 25 years old

4) Note: Women who have had a prior history of colorectal cancer or polyps will not be excluded unless they meet one of the above exclusion criteria.

Links

Registration Number: NCT00508846
Study Information on Clinical Trials Registry (clinicaltrials.gov)